Triple Treatment with Octreotide, Galanin and Serotonin is a Promising Therapy for Colorectal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|16|2107-2117

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.16, 2005-06, pp. : 2107-2117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Treatment with Octreotide, Galanin and Serotonin in Gastrointestinal Malignancies

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 6, 2005-09 ,pp. : 439-443

Bentham Science Publishers

Access to resources Recommend Favorite

Capecitabine, oxaliplatin plus erlotinib is promising for the treatment of metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Epigenetic Drug Therapy in the Treatment of Colorectal Cancer

By  

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2701-2709

Bentham Science Publishers

Access to resources Recommend Favorite

FOLFOXIRI promising in metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

BOND: Cetuximab a promising new agent for colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite